Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:04 am
Author: Getaka|Social: XLinkedIn

Hemant Surgical Industries Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹334.88Undervalued by 31.33%vs CMP ₹255.00

P/E (32.0) × ROE (13.6%) × BV (₹94.30) × DY (2.00%)

₹100.74Overvalued by 60.49%vs CMP ₹255.00
MoS: -153.1% (Negative)Confidence: 68/100 (Moderate)Models: All 9: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹171.9723%Over (-32.6%)
Graham NumberEarnings₹137.3416%Over (-46.1%)
Earnings PowerEarnings₹12.6311%Over (-95%)
DCFCash Flow₹35.0414%Over (-86.3%)
Net Asset ValueAssets₹94.477%Over (-63%)
EV/EBITDAEnterprise₹36.109%Over (-85.8%)
Earnings YieldEarnings₹88.907%Over (-65.1%)
ROCE CapitalReturns₹163.917%Over (-35.7%)
Revenue MultipleRevenue₹82.185%Over (-67.8%)
Consensus (9 models)₹100.74100%Overvalued
Key Drivers: EPS CAGR -48.6% drags value — could be higher if earnings stabilize. | Wide model spread (₹13–₹172) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -48.6%

*Investments are subject to market risks

Investment Snapshot

62
Hemant Surgical Industries Ltd scores 62/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health72/100 · Strong
ROCE 16.4% GoodROE 13.6% GoodD/E 0.49 ModerateInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money60/100 · Moderate
FII holding up 0.15% (6mo) Slight increaseDII holding up 8.84% MF buyingPromoter decreased by 14.66% CautionShareholders down 38% Consolidation
Earnings Quality50/100 · Moderate
OPM stable around 10% Steady
Quarterly Momentum78/100 · Strong
Revenue (4Q): +7% YoY GrowingProfit (4Q): +12% YoY PositiveOPM: 12.0% (up 5.0% YoY) Margin expansion
Industry Rank45/100 · Moderate
P/E 32.0 vs industry 32.0 In-lineROCE 16.4% vs industry 16.4% Average3Y sales CAGR: 2% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:04 am

Market Cap 332 Cr.
Current Price 255
Intrinsic Value₹100.74
High / Low 367/90.0
Stock P/E32.0
Book Value 94.3
Dividend Yield0.00 %
ROCE16.4 %
ROE13.6 %
Face Value 10.0
PEG Ratio-0.66

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Hemant Surgical Industries Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Hemant Surgical Industries Ltd 332 Cr. 255 367/90.032.0 94.30.00 %16.4 %13.6 % 10.0
Industry Average332.00 Cr255.0032.0094.300.00%16.40%13.60%10.00

All Competitor Stocks of Hemant Surgical Industries Ltd

Quarterly Result

MetricSep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025
Sales 51584858495864
Expenses 47524451455257
Operating Profit 4637468
OPM % 8%11%7%13%7%10%12%
Other Income 1132232
Interest 1110112
Depreciation 0011111
Profit before tax 4658467
Tax % 36%18%17%27%29%18%25%
Net Profit 2546355
EPS in Rs 48.126.933.755.633.054.744.15

Last Updated: January 1, 2026, 10:16 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: December 15, 2025, 5:14 am

MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 51565660101109106107122
Expenses 4853535795989597109
Operating Profit 233361110913
OPM % 5%5%5%5%6%10%10%9%11%
Other Income 000122455
Interest 112222123
Depreciation 010111111
Profit before tax 1111610131113
Tax % 10%8%41%9%25%24%23%23%
Net Profit 11015810810
EPS in Rs 50.7661.0227.0073.43248.929.959.397.798.89
Dividend Payout % 0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2018-20192019-20202021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)0.00%-100.00%400.00%60.00%25.00%-20.00%
Change in YoY Net Profit Growth (%)0.00%-100.00%500.00%-340.00%-35.00%-45.00%

Hemant Surgical Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2018-2019 to 2024-2025.

Growth

Last Updated: September 5, 2025, 6:30 am

Balance Sheet

Last Updated: December 10, 2025, 2:49 am

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 222228101013
Reserves 565811164453110
Borrowings 911141410773153
Other Liabilities 121423153234385439
Total Liabilities 283344405465100148214
Fixed Assets 7810111213184034
CWIP 00000001217
Investments 001010513
Other Assets 2125332942517794160
Total Assets 283344405465100148214

Reserves and Borrowings Chart

Cash Flow

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 002-4126-49
Cash from Investing Activity + 00-2-2-0-3-12-30
Cash from Financing Activity + 0025-8-12118
Net Cash Flow 002-2435-4
Free Cash Flow 00-1-7122-13-25
CFO/OP 0%0%68%-127%197%84%-9%126%

Free Cash Flow

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-7.00-8.00-11.00-11.00-4.004.003.00-22.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 3536352656587570
Inventory Days 6473125113576799205
Days Payable 102971438992110116188
Cash Conversion Cycle -312175121155887
Working Capital Days 1223-2841-1925261
ROCE %15%12%14%32%45%30%16%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2023Mar 2024Sep 2024Mar 2025Sep 2025
Promoters 73.56%73.56%73.56%73.56%58.90%
FIIs 0.03%0.00%0.00%0.39%0.15%
DIIs 4.26%1.97%1.13%1.11%10.81%
Public 22.14%24.47%25.31%24.93%30.13%
No. of Shareholders 7221,2291,2481,229758

Shareholding Pattern Chart

No. of Shareholders

Hemant Surgical Industries Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25
FaceValue 10.00
Basic EPS (Rs.) 7.70
Diluted EPS (Rs.) 7.70
Cash EPS (Rs.) 9.07
Book Value[Excl.RevalReserv]/Share (Rs.) 60.51
Book Value[Incl.RevalReserv]/Share (Rs.) 60.51
Revenue From Operations / Share (Rs.) 102.14
PBDIT / Share (Rs.) 13.50
PBIT / Share (Rs.) 12.14
PBT / Share (Rs.) 10.02
Net Profit / Share (Rs.) 7.70
NP After MI And SOA / Share (Rs.) 7.70
PBDIT Margin (%) 13.21
PBIT Margin (%) 11.88
PBT Margin (%) 9.81
Net Profit Margin (%) 7.54
NP After MI And SOA Margin (%) 7.54
Return on Networth / Equity (%) 12.72
Return on Capital Employeed (%) 14.55
Return On Assets (%) 5.42
Long Term Debt / Equity (X) 0.36
Total Debt / Equity (X) 0.49
Current Ratio (X) 1.45
Quick Ratio (X) 0.74
Interest Coverage Ratio (X) 6.40
Interest Coverage Ratio (Post Tax) (X) 4.65
Enterprise Value (Cr.) 125.52
EV / Net Operating Revenue (X) 1.18
EV / EBITDA (X) 8.90
MarketCap / Net Operating Revenue (X) 0.97
Price / BV (X) 1.65
Price / Net Operating Revenue (X) 0.97
EarningsYield 0.07

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Hemant Surgical Industries Ltd. is a Public Limited Listed company incorporated on 27/03/1989 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L33110MH1989PLC051133 and registration number is 051133. Currently Company is involved in the business activities of Other Hospital and Medical Care Activities. Company's Total Operating Revenue is Rs. 106.53 Cr. and Equity Capital is Rs. 10.44 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Medical Equipment & Accessories502, 5th Floor, Ecstasy Business Park Co-Op Socteiy Limited, Mumbai Maharashtra 400080Contact not found
Management
NamePosition Held
Mr. Hanskumar ShahChairman & Managing Director
Mr. Kaushik Hanskumar ShahWholeTime Director & CFO
Mr. Hemant Praful ShahWhole Time Director
Mrs. Nehal Babu KareliaNon Executive Director
Mr. Ketan Chandrakat DaveIndependent Director
Mrs. Kshama DharnidharkaIndependent Director

FAQ

What is the intrinsic value of Hemant Surgical Industries Ltd and is it undervalued?

As of 13 April 2026, Hemant Surgical Industries Ltd's intrinsic value is ₹100.74, which is 60.49% lower than the current market price of ₹255.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (13.6 %), book value (₹94.3), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Hemant Surgical Industries Ltd?

Hemant Surgical Industries Ltd is trading at ₹255.00 as of 13 April 2026, with a FY2026-2027 high of ₹367 and low of ₹90.0. The stock is currently in the middle of its 52-week range. Market cap stands at ₹332 Cr..

How does Hemant Surgical Industries Ltd's P/E ratio compare to its industry?

Hemant Surgical Industries Ltd has a P/E ratio of 32.0, which is below the industry average of 32.00. This is broadly in line with or below the industry average.

Is Hemant Surgical Industries Ltd financially healthy?

Key indicators for Hemant Surgical Industries Ltd: ROCE of 16.4 % indicates efficient capital utilization. Dividend yield is 0.00 %.

Is Hemant Surgical Industries Ltd profitable and how is the profit trend?

Hemant Surgical Industries Ltd reported a net profit of ₹8 Cr in Mar 2025 on revenue of ₹107 Cr. Compared to ₹5 Cr in Mar 2022, the net profit shows an improving trend.

Does Hemant Surgical Industries Ltd pay dividends?

Hemant Surgical Industries Ltd has a dividend yield of 0.00 % at the current price of ₹255.00. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Hemant Surgical Industries Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports